- FDA is the source of guidance for U.S. healthcare providers.
- FDA is the source of guidance for U.S. healthcare providers.
- FDA is the source of guidance for U.S. healthcare providers.
- FDA is the source of guidance for U.S. healthcare providers.
Manning provided reformulation guidance while a Kalsec study informed regulatory scrutiny involving the FDA.
1 report, 1 independent
Updated Jul 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Manning provided reformulation guidance while a Kalsec study informed regulatory scrutiny involving the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Kalsec
American producer of food additives
Nothing else this week.
-
Manning
town in Alberta
Nothing else this week.
- FDA
Related events
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- The FDA has issued a Major Amendment regarding AxoGen's submission on August 25, 2025.
- FDA reviewed protocol amendment and interim safety data for a company's product.
- NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.
Coverage
Newest first; wire copies grouped- fooddive.comFuture proofing CPG portfolios with natural ingredients